Literature DB >> 18415472

[Prevalence of migraine in Germany.].

F B Ensink1, M Bautz, B Brüggenjürgen, G G Hanekop.   

Abstract

INTRODUCTION: There are no valid data available for Germany on the prevalence of migraine using the new diagnostic and classification criteria of the International Headache Society (IHS). SAMPLE AND METHODS: Therefore, a survey on migraine prevalence was carried out on a representative sample of 2000 residents aged 16 to 69 years of the states of the former West Germany. The questionnaire incorporated the new criteria of the IHS and the diagnosis of migraine was based on the corresponding classification.
RESULTS: Some 23.4% of the sample suffered from headaches, and 3.6% were identified as having migraine according to the IHS classification. The prevalence of migraine was 5.3% in women and 1.7% in men. The highest prevalence of 5.7% was found in the group aged 40-49 years. By extending the 4-72 h IHS attack duration criterion to 2-72 h, the migraine prevalence increased from 3.6% to 4.4%. DISCUSSION: For methodological reasons our study may underestimate the true prevalence of migraine in Germany. Taking our rather "conservative" figures into account, our study reveals, however, that there are more than 2 million migraine sufferers in Germany between 16 and 69 years of age.

Entities:  

Year:  1994        PMID: 18415472     DOI: 10.1007/BF02530392

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  17 in total

1.  Epidemiologic study of migraine symptoms in young women.

Authors:  R E Markush; H R Karp; A Heyman; W M O'Fallon
Journal:  Neurology       Date:  1975-05       Impact factor: 9.910

2.  Towards a definition of migraine headache.

Authors:  J N Blau
Journal:  Lancet       Date:  1984-02-25       Impact factor: 79.321

3.  Frequency of migraine among an unselected group of employees and variation of prevalence according to different diagnostic criteria.

Authors:  T Koehler; E Buck-Emden; K Dulz
Journal:  Headache       Date:  1992-02       Impact factor: 5.887

4.  A nationwide survey of migraine in France: prevalence and clinical features in adults. GRIM.

Authors:  P Henry; P Michel; B Brochet; J F Dartigues; S Tison; R Salamon
Journal:  Cephalalgia       Date:  1992-08       Impact factor: 6.292

5.  Migraine and non-migrainous headaches. A community survey in Jerusalem.

Authors:  J H Abramson; C Hopp; L M Epstein
Journal:  J Epidemiol Community Health       Date:  1980-09       Impact factor: 3.710

6.  Epidemiology of headache and migraine in women.

Authors:  W E Waters; P J O'Connor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-04       Impact factor: 10.154

7.  Migraine: intelligence, social class, and familial prevalence.

Authors:  W E Waters
Journal:  Br Med J       Date:  1971-04-10

8.  Grading the severity of chronic pain.

Authors:  Michael Von Korff; Johan Ormel; Francis J Keefe; Samuel F Dworkin
Journal:  Pain       Date:  1992-08       Impact factor: 6.961

9.  Questionnaire versus clinical interview in the diagnosis of headache.

Authors:  B K Rasmussen; R Jensen; J Olesen
Journal:  Headache       Date:  1991-05       Impact factor: 5.887

10.  Characteristics of life headache histories in a nonclinic population.

Authors:  D K Ziegler; R S Hassanein; J R Couch
Journal:  Neurology       Date:  1977-03       Impact factor: 9.910

View more
  2 in total

1.  [The clinical picture of the chronic pain patient-Analysis of a pain outpatient clinic using headache as an example.].

Authors:  I Gralow; C Schwerdt; H J Hannich; B Meyer; A Hürter; C Witte
Journal:  Schmerz       Date:  1995-07       Impact factor: 1.107

2.  Improving quality in population surveys of headache prevalence, burden and cost: key methodological considerations.

Authors:  Timothy J Steiner; Lars Jacob Stovner; Mohammed Al Jumah; Gretchen L Birbeck; Gopalakrishna Gururaj; Rigmor Jensen; Zaza Katsarava; Luiz Paulo Queiroz; Ann I Scher; Redda Tekle-Haimanot; Shuu-Jiun Wang; Paolo Martelletti; Tarun Dua; Somnath Chatterji
Journal:  J Headache Pain       Date:  2013-10-25       Impact factor: 7.277

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.